We are live on ! Find out more
BBHC

Brown Brothers Harriman & Co Portfolio holdings

AUM $18.6B
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
-1.28%
1 Year Est. Return
+15.81%
3 Year Est. Return
+66.02%
5 Year Est. Return
+80.97%
10 Year Est. Return
+273.41%
AUM
$14.3B
AUM Growth
-$447M
Cap. Flow
-$74.1M
Cap. Flow %
-0.52%
Top 10 Hldgs %
38.85%
Holding
1,613
New
193
Increased
474
Reduced
339
Closed
155

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$99.2M
2
PGR icon
Progressive
PGR
+$85.9M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$66.1M
4
PM icon
Philip Morris
PM
+$21.2M
5
NKE icon
Nike
NKE
+$18.7M

Sector Composition

Rank Sector Weight
1 Technology 25.18%
2 Financials 19.1%
3 Healthcare 12.62%
4 Industrials 9.06%
5 Consumer Discretionary 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
151
Caterpillar
CAT
$385B
$4.83M 0.03%
13,308
+58
+0.4% +$22.5K
USB icon
152
US Bancorp
USB
$100B
$4.75M 0.03%
99,354
-19,137
-16% -$941K
AMGN icon
153
Amgen
AMGN
$226B
$4.74M 0.03%
18,196
-2,197
-11% -$652K
KMB icon
154
Kimberly-Clark
KMB
$35.9B
$4.7M 0.03%
35,867
+148
+0.4% +$20.2K
PFE icon
155
Pfizer
PFE
$154B
$4.7M 0.03%
177,073
-33,854
-16% -$918K
IVW icon
156
iShares S&P 500 Growth ETF
IVW
$77.4B
$4.68M 0.03%
46,140
+1,440
+3% +$144K
NHC icon
157
National Healthcare
NHC
$3.46B
$4.68M 0.03%
43,500
DIS icon
158
Walt Disney
DIS
$178B
$4.61M 0.03%
41,386
+202
+0.5% +$21.2K
VWO icon
159
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$4.58M 0.03%
104,097
-2,167
-2% -$101K
BMY icon
160
Bristol-Myers Squibb
BMY
$132B
$4.57M 0.03%
80,832
-5,597
-6% -$313K
FDX icon
161
FedEx
FDX
$76.9B
$4.57M 0.03%
16,233
-112
-0.7% -$31.3K
MCO icon
162
Moody's
MCO
$82.8B
$4.56M 0.03%
9,643
+6,156
+177% +$2.94M
XLV icon
163
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$4.53M 0.03%
32,919
+15
+0% +$2.19K
SPHQ icon
164
Invesco S&P 500 Quality ETF
SPHQ
$19.7B
$4.5M 0.03%
67,200
CE icon
165
Celanese
CE
$4.88B
$4.43M 0.03%
63,972
-102,639
-62% -$9.86M
VYM icon
166
Vanguard High Dividend Yield ETF
VYM
$83.7B
$4.34M 0.03%
34,020
-1,012
-3% -$132K
TGT icon
167
Target
TGT
$69B
$4.19M 0.03%
31,009
-2,505
-7% -$359K
PNC icon
168
PNC Financial Services
PNC
$100B
$4.17M 0.03%
21,633
-20
-0.1% -$3.93K
ACN icon
169
Accenture
ACN
$109B
$4.17M 0.03%
11,844
+306
+3% +$110K
BX icon
170
Blackstone
BX
$113B
$4.17M 0.03%
24,158
+63
+0.3% +$11K
QCOM icon
171
Qualcomm
QCOM
$170B
$4.1M 0.03%
26,693
+1,000
+4% +$164K
CL icon
172
Colgate-Palmolive
CL
$74.3B
$4.03M 0.03%
44,275
-3,946
-8% -$377K
DLN icon
173
WisdomTree US LargeCap Dividend Fund
DLN
$6.4B
$4M 0.03%
51,440
CI icon
174
Cigna
CI
$73.6B
$3.76M 0.03%
13,607
+161
+1% +$51.3K
SHW icon
175
Sherwin-Williams
SHW
$88.1B
$3.69M 0.03%
10,852
+131
+1% +$48.9K

Similar funds

Brown Brothers Harriman & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Brown Brothers Harriman & Co held 1,613 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Brown Brothers Harriman & Co's Q4 2024 filing shows 193 new, 474 increased, 339 reduced and 155 closed positions. Its largest new stake was West Pharmaceutical: 94,988 shares worth $31.1M. The largest sale was Booking.com, an estimated $99.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Brown Brothers Harriman & Co's largest Q4 2024 buy was West Pharmaceutical: 94,988 shares worth $31.1M.
  • Brown Brothers Harriman & Co added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $61.8M increase.
  • Brown Brothers Harriman & Co's biggest Q4 2024 reduction was Booking.com, cutting an estimated $99.2M.
  • Brown Brothers Harriman & Co fully exited Watts Water Technologies in Q4 2024, selling an estimated $1.04M.
  • Brown Brothers Harriman & Co's ten largest holdings make up 39% of its $14.3B portfolio in Q4 2024.
  • Brown Brothers Harriman & Co opened 193 new positions and closed 155 in Q4 2024.
  • Brown Brothers Harriman & Co's portfolio value fell 3% quarter-over-quarter to $14.3B.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2024, filed 12 Feb 2025.